OTCMKTS:EVTCY Evotec (EVTCY) Stock Price, News & Analysis $1.56 -0.02 (-1.27%) As of 11/16/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsNews and TrendsSEC Filings About Evotec Stock (OTCMKTS:EVTCY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Evotec alerts:Sign Up Key Stats Today's Range$1.56▼$1.6050-Day Range$1.35▼$1.8652-Week Range$14.22▼$26.57Volume45,903 shsAverage Volume2,407 shsMarket Capitalization$515.14 millionP/E Ratio3.80Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Evotec SE is a drug discovery and development company headquartered in Hamburg, Germany. Founded in 1993, the company works with pharmaceutical and biotechnology companies, as well as academic and research organizations, to advance medicines from early research through development. Evotec provides integrated research services and technology platforms for identifying and developing drug candidates. Its work spans areas including neuroscience, oncology, metabolic disease and infectious disease. Through Just-Evotec Biologics, it also supports the development and manufacture of biologic medicines. The company serves partners internationally, with operations in Europe and North America. Its business combines fee-for-service research with collaborative and partnership-based drug development.AI Generated. May Contain Errors. Read More Receive EVTCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVTCY Stock News HeadlinesEvotec SE Reports Earnings Results for the Nine Months Ended September 30, 2026November 5, 2026 | marketscreener.comMEvotec SE : Berenberg reiterates its Neutral ratingOctober 16, 2026 | marketscreener.comMTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.November 17 at 1:00 AM | Base Camp Trading (Ad)Evotec SE : Gets a Neutral rating from Deutsche BankOctober 15, 2026 | marketscreener.comMEvotec Appoints Former Novo Nordisk Executive Joanna Holbrook As Chief Scientific Officer; Stock UpOctober 15, 2026 | rttnews.comEvotec Sees 9-Month Results Above Market; Reiterates FY26 OutlookOctober 14, 2026 | rttnews.comBerenberg downgrades Evotec SE - Depositary Receipt to hold from buySeptember 25, 2026 | msn.comBerenberg downgrades Evotec SE to hold from buySeptember 25, 2026 | msn.comSee More Headlines EVTCY Stock Analysis - Frequently Asked Questions How have EVTCY shares performed this year? Evotec's stock was trading at $3.08 at the start of the year. Since then, EVTCY shares have decreased by 49.4% and is now trading at $1.56. When did Evotec's stock split? Evotec shares split on Wednesday, October 20th 2021.The 3-1 split was announced on Wednesday, October 20th 2021. The newly minted shares were payable to shareholders after the closing bell on Wednesday, October 20th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. Does Evotec have any subsidiaries? Evotec subsidiaries include Central Glass Germany. GmbH, Central Glass Germany, Rigenerand Srl, GlaxoSmithKine's the Verona site, Just-Evotec Biologics, Aptuit, Cyprotex, and more. How do I buy shares of Evotec? Shares of EVTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Evotec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evotec investors own include Evotec (EVT), Alnylam Pharmaceuticals (ALNY), Exelixis (EXEL), NetEase (NTES), NVIDIA (NVDA), OPKO Health (OPK) and First Majestic Silver (AG). Company Calendar Today11/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolOTCMKTS:EVTCY CIK1412558 Webwww.evotec.com Phone(494) 056-0810Fax49-40-5608-1222Employees4,200Year Founded1993Profitability EPS (Trailing Twelve Months)$0.41 Trailing P/E Ratio3.80 Forward P/E RatioN/A P/E GrowthN/ANet Income$7.14 million Net Margins20.85% Pretax Margin23.90% Return on Equity16.02% Return on Assets7.81% Debt Debt-to-Equity Ratio0.53 Current Ratio2.57 Quick Ratio2.50 Sales & Book Value Annual Sales$572.16 million Price / Sales0.90 Cash Flow$0.01 per share Price / Cash Flow105.53 Book Value$2.52 per share Price / Book0.62Miscellaneous Outstanding Shares330,221,000Free FloatN/AMarket Cap$515.14 million OptionableNot Optionable Beta0.98 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:EVTCY) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredThe $40 trillion number nobody won on Tuesday will touchDemocrats took the House and Senate on election night, but the $40 trillion national debt and the $1 trillion ...Vault Metal | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.